New injection may ease back pain for ankylosing spondylitis patients
NCT ID NCT07633730
First seen Jun 17, 2026 · Last updated Jun 17, 2026
Summary
This study tests whether a nerve block injection (erector spinae plane block) can reduce persistent back pain in people with ankylosing spondylitis whose disease is otherwise under control. About 15 adults aged 18-65 will receive the injection and report pain levels. The goal is to see if this simple procedure can offer extra relief when standard treatments aren't enough.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REGIONAL ANESTHESIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Marmara University Faculty of Medicine Pendik Training and Research Hospital
RECRUITINGIstanbul, Pendik, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.